Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Or filing fees!
Do you suppose we will get a PR, on the DCVAX-L and Poly-ICIC combo file informing us of its completion?
It's 15B until it isn't.
Do you think Pfizer's 43B acquisition of Seagen is a threat?
Seagen is a leading developer of medicine called antibody-drug conjugates, or ADCs, which are designed to kill cancer cells and spare healthy ones. ADCs use antibodies to deliver small molecule drugs directly to a tumor site, which may reduce side effects and offer greater efficacy, according to Seagen’s website.
One billion is way to little. The MM's probably made that much on May 10th last year.
Any settlement without a mandate to stop is not a victory.
Cemented = Approval = Final = Done = Guaranteed
No other definition makes sense.
Sounds of desperation!
"Judge Wood declined defendants request"
Thus we should see short covering accelerate!!
And don't forget the political pressure the MHRA must be feeling from Parliament!
I suppose many there want to keep their jobs so they have an incentive to find ways to improve the process.
What better way, then to do it with a high profile treatment for GBM.
I also suspect the volume will keep on increasing as shorts try to cover knowing approval is imminent.
Not much time left!
Let's go! N..W..B..O..
Thanks for posting...Great article mentioning NWBO.
"MHRA currently offers a 150-day assessment route for high-quality national MA applications and the option for applications to be fast tracked if there is compelling evidence"
I read this as the company PR the current offer of a 150-day process, however, the process will be fast tracked since there is overwhelming compelling evidence of efficacy (and not to mention safety)!!
So, lets see how much time is taken off the 150 if we are under the fast track scenario...
60 days would take us to February 18th
75 days would take us to March 4th
90 days would take us to March 19th
Surely, fast track would be 100 days or less.
I have all the fudsters on ignore and I will be placing anyone who replies on ignore too!
Enough of the BS...Replying IS EXACTLY what they want. If you are not intelligent to know that, then ignore you go!
Just dont comprehend why anyone would give credence to them.
This board has become cesspool!!
"there will be significant off-label of DCVax in cancer therapy"
Though I agree, I am concern with manufacturing unless dstock is correct about Merck's new facilities.
I think so!!!
Well orchestrated release and article!
Just like JAMA!!
I have a feeling the Nature article will be released on the heels of this!!
you have him on ignore then why do you reply?
this board is turning to mud
stop giving them credibility by replying to their text. Just ignore them is the BEST course of action.
I liked this part....
"In addition to internal developments, companies will likely look for opportunities to acquire more drugs, particularly those in late-stage development that are close to entering the market, said Arda Ural, EY’s Americas industry markets leader in health sciences and wellness.
The biotech and pharmaceutical industry is also starting the year off with about $1.4 trillion on hand to make deals, he added.
Wouldn't it be interesting if 2 or more BP's joined hands to buy NWBO, to lessen the sting of the purchase price?!
I wonder if yesterday's late buying had to do with this filing? It pays to stay on top of the filings!!
You gotta love Laura Posner!
I love these statements:
1) But the R&R went even further, finding that the Complaint pled additional facts about Defendants’ spoofing activity that make the inference of scienter even stronger, including the fact that they each signed yearly certifications in accordance with FINRA rules attesting to the fact that they had sufficient policies in place to detect and prohibit manipulative trading.
2)Defendants do not cite a single spoofing case agreeing with any of their objections to this element and offer no reason why this Court should depart from all others that have considered and rejected these same arguments
3) Indeed, Defendants cite to no case (because there is none) that limits “parking” allegations in the way they suggest, and the R&R is correct that “it is not essential for a spoofing complaint to include allegations of ‘parking’ in order to survive a motion to dismiss” in the first place.
4)They also assert that the R&R failed to consider competing inferences, but what they really mean is that the R&R failed to adopt their version of the facts instead of presuming the well-pled allegations in the Complaint to be true,
"should they be hiring staff"
Not if a deal is waiting approval!!
The best medicines to avoid replying. Just place them on ignore...I just can't figure why reply and lend them credibility?
If the reason is to inform newbies of their shxt, the newbies will figure it out o their own...
Ignore all the fudsters!!
My take, it was submitted on the 21st and validated on the 22nd.
"What happened to the belief that no deal will be made until the share price is at least 10x what it is now?"
Why did I say that?
You are the master baiter for sure so to the ignore list you go.
"I’m betting any and all partnerships hinge upon MHRA approval."
Based on the amount of upfront and milestone payments, our BP partner wants to be 100% certain of approval!!
That is the only way they will agree to the huge amount of money being discussed/already agreed uponl!!!
Approval and then Deal...days apart at most!!
" A good faith combo trial with upfront and milestone payments..."
I would love to see an upfront payment in excess of $2B with a special dividend attached. That would truly fry and irk the shorts.
If we are so close to approval and generating revenue a special dividend would be ideal to have a great laugh at the hedge funds/MM's expense.
"All of these were approved for all malignant gliomas."
In one of my discussions, it was emphasized we submitted only for GBM.
At the time, I felt it was odd ,but after reading your "discovery" I do sense the approval for all malignant gliomas will be a shock and awe moment for many.
"Show me some of these 900% premium buyouts"....
Immunomedics, Inc. acquired by Gilead Sciences for $8.4 billion in 2020: This translates to a staggering 1,062% premium over Immunomedics' closing share price just before the acquisition news broke. The deal was driven by Gilead's interest in acquiring Trodelvy, Immunomedics' lead drug for treating triple-negative breast cancer.
"You would think we would be the first prospect due to our technology."
Unless one of Merck's competitors anted up more $$$ and now Merck is scrambling in attempt to find something that may extend keytruda.
However, I believe Merck knows what is at stake and they will soon be revealed as our BIG partner.
Giddy up!!!
The borrowed rate jumped from 6.25% yesterday to 7.50% this morning, suggesting the short have returned.
He truly seemed disappointed on how others in Congress take advantage of situations...case in point....The missile replenishment with Raytheon.
He is truly all about doing the right thing. Regardless of political persuasion. I can't stress this enough.
We need more like him!!
No worries...At least it wan't an imposter!
and 1 day until 1/24.
LOL!!
This was not you???
biosectinvestor
Tuesday, January 23, 2024 9:57:10 AM
I honestly do not think Rep Tim Burchett would support much on that page including Sen Ossoff’s proposed regulation of members of Congress.
In reply to your PM…Oh yes he does!!
2nd Congressional district of Tennessee.
He is all about integrity over the dollar!
Congress needs more like him!!!
Google " GOP Honeypot".
He calls out, how his colleagues are blackmailed.
Make you wonder why he didn't support McCarthy for speaker?
A big part why it is hard to do the right thing.
If I am not mistaken, Nature usually publishes a new issue on Wednesdays and tomorrow is Wednesday 1/24.
Credit goes to DI on that. I remember one time using my house example and he said here is one that's better...
You need to get up to date on the Stock Act…
https://campaignlegal.org/update/stock-act-failed-effort-stop-insider-trading-congress